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Fibrosis is a major cause of progressive organ dysfunction in several chronic pulmonary 
diseases. Rho associated coiled-coil forming kinase (ROCK) has shown to be involved in 
myofibroblast differentiation driven by altered matrix stiffness in fibrotic state. There are two 
known ROCK isoforms in human, ROCK1 (ROKβ) and ROCK2 (ROKα), but specific role of each 
isoform in myofibroblast differentiation in lung fibrosis remains unknown. To study this, we 
developed a Gelatin methacryloyl (GelMA) hydrogel based culture system with different 
stiffness levels relevant to healthy and fibrotic lungs. We have shown that stiff matrix and not 
soft matrix, can induce myofibroblast differentiation with high αSMA expression. 
Furthermore, our data confirm that the inhibition of ROCK signalling by a pharmacological 
inhibitor (i.e. Y27632) attenuates stiffness induced αSMA expression and fibre assembly in 
myofibroblasts. To assess the role of ROCK isoforms in this process we used siRNA to knock 
down the expression of each isoform. Our data showed that knocking down either ROCK1 or 
ROCK2 did not result in a reduction in αSMA expression in myofibroblasts on stiff matrix as 
opposed to soft matrix where αSMA expression was reduced significantly. Paradoxically, on 
stiff matrix, the absence of one isoform (particularly ROCK2) exaggerated αSMA expression 
and led to thick fibre assembly. Moreover complete loss of αSMA fibre assembly was seen 
only in the absence of both ROCK isoforms suggesting that both isoforms are implicated in 
this process. Overall our results indicate the differential role of ROCK isoforms in 











Pulmonary fibrosis is a major cause for progressive organ dysfunction in several pulmonary 
diseases like idiopathic pulmonary fibrosis (IPF), asbestosis and chronic granulomatous 
diseases such as sarcoidosis. Fibrosis is multifactorial and characterised by (1) fatal 
accumulation of extracellular matrix (ECM) proteins, (2) hyperproliferation of fibroblasts and 
(3) their differentiation into myofibroblasts in clusters, termed as fibrotic foci that collectively 
lead to disruption of normal lung architecture.  
In lung fibrosis, myofibroblasts are the most predominant cell type found in fibrotic foci. 
Functionally, they share the contractile features of smooth muscle cell with the expression 
and polymerisation of smooth muscle actin isoform (α-SMA) (1, 2). Unlike in normal wound 
healing, in which myofibroblasts contract the wound and undergo apoptosis after the healing 
process, in fibrosis myofibroblasts become resistance to apoptosis and produce excessive 
extracellular matrix (ECM) like collagen. Together with excessive collagen deposition from 
myofibroblasts, increased cross linking of the collagen makes extracellular matrix more rigid 
in lung fibrosis (3, 4). In the bleomycin induced lung fibrosis mouse model, ECM rigidity of 
lung is about 6 times higher than normal lung (5). Moreover decellularised IPF lungs showed 
significantly higher matrix stiffness, nearly 9 times higher than that of normal lungs (2 kPa vs 
17 kPa)(6). Fibroblasts grown on the stiff matrix also trigger further increase in expression of 
α-SMA independent of TGF-β (7). Rather than simply being a consequence of fibrosis, the 
increase in matrix stiffness has been recognised as active participant in promoting fibroblast 
activation and myofibroblast transformation by establishing a feedback loop for ongoing 
fibrosis (5, 8-11).  
Recently Rho associated coiled-coil forming kinase (ROCK) has shown to be involved in lung 
fibrosis (12-14) and also in stiffness driven myofibroblast differentiation by intrinsic 
mechanotransduction mechanism (15). The ROCK belongs to the family of serine/threonine 
kinase and a major downstream effector of the small GTPase RhoA. They are involved in 
normal cell physiology function such as contractibility of smooth muscle cells through myosin 
II activity and formation of focal adhesion and stress fibre in non-muscle cells through myosin 
phosphatase (16, 17). In response to matrix stiffness, through ROCK activation, lung 
fibroblasts demonstrate increased F actin polymerisation, increased MRTF-A (myocardin 
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related transcription factor A) nuclear localisation, increased αSMA protein expression and 
stress fibre assembly through MRTFA-SRF (serum response factor) dependent pathway (7, 9, 
18).  
There are two known isoforms of ROCK in human, ROCK1 (ROKβ) and ROCK2 (ROKα). These 
two isoforms have high amino acid sequence homology (65%) and identity (92%) in their 
kinase domains (19). Pharmacological ROCK inhibitors such as Y27632 or Fasudil (20, 21) were 
shown to be efficient in preventing myofibroblast differentiation in both in vitro (7) and in 
vivo fibrosis models (15). This clearly exhibits ROCK’s role in sensing extracellular matrix 
stiffness changes and subsequent activation of mechanotransduction pathways in fibrosis. 
However, given the high degree of homology within the kinase domain and the downstream 
pathway redundancy between two ROCK isoforms, it is not possible to determine the role of 
each isoform in stiffness induced myofibroblast differentiation through using 
pharmacological inhibitors only (22). Although ROCK inhibitors have shown promising effect 
in controlling fibrosis, their off target effect when used in high dose and non-selectivity 
against other kinases like protein kinase C related kinase (PRK) at the same concentration 
necessary for ROCK inhibition, limits their efficacy(21). Moreover, advances in gene silencing 
using short interfering RNA (SiRNA) as well as in knockout animal models, have the potential 
to provide additional insight into ROCK isoform selectivity. Recent examples include studies 
focused on the differential role of ROCK isoforms in contractile function of vascular smooth 
muscle cells (19, 23) and cancer cell migration (24).  
A growing body of evidence indicates the importance of ROCK isoforms in different 
pathologies. Therefore, detail understanding of how each of the ROCK isoforms are involved 
in myofibroblast differentiation in lung fibrosis pathophysiology could pave the way for the 
development of more efficient therapeutic approaches to control lung fibrosis in an isoform 
specific manner (13, 22). In this study, we investigated the role of each ROCK isoform in 
stiffness induced myofibroblast differentiation in pulmonary fibrosis by using physiologically 
relevant ECM based hydrogel scaffolds with tuneable stiffness.   
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Materials and methods 
Preparation of different percentages of GelMA hydrogels  
Gelatin methacryloyl (GelMA) macromer as a white porous foam (kindly provided by 
Khademhosseini Lab, Harvard) was prepared as previously described (25). Prior to fabrication 
of GelMA hydrogels, 1cm2 glass chips was prepared from TMSPMA treated glass slide and 
followed by PolyHEMA coating as previously described (26). Briefly, different percentages of 
GelMA (5%, 10% and 15%) was prepared by dissolving in 0.25% (w/v) of photoinitiator [Sigma-
410896] in DPBS at 60◦C and then UV crosslinked (Figure S1). The mechanical properties of 
hydrogel was characterised according to established protocol (27).  
Si RNA Gene silencing of ROCK isoform 
Human lung fibroblast cell line (MRC-5) obtained from ATCC, was routinely cultured as 
previously described (28). Both SiRNA targeting human ROCK1 and ROCK2 (SiGENOME SMART 
pool) and non-targeting SiRNA control were purchased from Dharmacon (GE Healthcare). 
Cells were transfected by DharmaFECT1 transfection agent (GE healthcare) according to 
manufacturer’s instruction. Lung fibroblasts (5x104) were seeded on the 5% and 15% GelMA 
hydrogel in non-tissue cultured treated 24 well plate overnight and changed into new plate 
before transfection. The efficiency and specificity of gene knock down was checked by RT-PCR 
and western blotting. Effective gene knock down was achieved at 50 nM of SiRNA of ROCK1 
and ROCK2 in 1:625 dilution of transfection agent after 48 hour transfection. 
Real time (qRT-PCR) analysis  
Total RNA was harvested using pure LinkTM RNA mini kit (Ambion) following Trizol extraction. 
100ng cDNA was synthesized using Superscript III first Strand Synthesis SuperMix (Invitrogen) 
according to manufacturer’s protocol. Real time PCR was performed with Brilliant III Ultra-







Western Blot analysis  
Before lysis, cells cultured on hydrogel were washed with cold PBS twice for 15 minutes on 
shaker at 4˚C to remove protein absorbed in hydrogel and then lysed using RIPA buffer with  
1x protease inhibitor (Sigma) for 30 min on ice. Protein samples (8 µg) were then separated 
by SDS-PAGE electrophoresis and followed by protein transfer onto a nitrocellulose 
membrane. Membranes were blocked in 5% BSA in TBS with 0.1% Tween at RT for 1 hr and 
then incubated with primary antibodies overnight at 4°C [anti αSMA (Sigma, A5228), anti-
alpha tubulin (Abcam); anti ROCK1 (C8F7) and ROCK2 (D1B1) (Cell Signalling)] followed by 
relevant HRP conjugated secondary antibody for an hour at RT.  
Immunofluorescence Confocal Imaging 
Immunofluorescent staining and confocal microscopy were performed as described in our 
previous study (29). All immunofluorescent images comparing 5% and 15% GelMA conditions 
are from the same experiment and also analysed together using same microscopy settings on 
the same day. 
Statistical Analysis 
Statistical analysis was performed using Graph Prism 6. Data are expressed as means ± 
Standard deviation (SD) and analysed by one way ANOVA and two way ANOVA where 
appropriate with Bonferroni post hoc test for multiple comparisons. Significance level was set 
at p < 0.05. 








Fabrication of GelMA based Hydrogel Scaffolds with Different stiffness   
Mechanical properties of the extracellular matrix environment have shown to be important in lung 
fibrosis progression (8). GelMA is a well-established ECM based hydrogel system for different types of 
cell culture and has easily tuneable mechanical properties (27, 30, 31). It is particularly relevant to 
studying lung fibrosis in which increased stiffness of ECM is mainly induced by collagen deposition.    
We first fabricated 5%, 10% and 15% GelMA hydrogels with 5mm2 diameter and 100m thickness 
(Figure S1). We then measured the mechanical properties of different percentage GelMA hydrogels 
using both compressive (Figure 1) and Young’s modulus (Figure S2). As shown in Figure 1, different 
percentages of GelMA hydrogel showed varying degree of stiffness with 3.650 ± 0.1 kPa (5% GelMA), 
15.15 ± 0.9 (10% GelMA) and 27.73 ± 0.8 kPa (15% GelMA). This range of stiffness in both compressive 
and Young’s modulus corresponds to the range of normal and fibrotic lung stiffness with 5% GelMA 
representing the normal lung stiffness while 10 and 15% being closer to fibrotic lung matrix (6).  
 
Figure 1. Mechanical properties of GelMA based Hydrogel 
platform with different percentages of GelMA. The stiffness 
of hydrogel [5%, 10% and 15% (w/v) GelMA] was measured 
in compressive modulus. Three independent sets of 
experiments for each condition were performed in triplicate. 
10% and 15% (w/v) GelMA were significantly different (****p 
< 0.001) compared to that of 5% (w/v) GelMA.  Mean ± SD.  
 
 
Increased substrate stiffness promote myofibroblast differentiation as evidenced by increased 
expression of αSMA protein in lung fibroblast  
As seen in Figure 2, there is a significant increase in αSMA mRNA and protein expression levels in lung 
fibroblasts with increasing substrate stiffness from normal lung (5% GelMA) to fibrotic lung (10% and 
15% GelMA) values. In addition, confocal immunostaining also confirms the assembly of αSMA stress 
fibre in lung fibroblast cultured on higher stiffness hydrogels.  Lung fibroblasts cultured on 10% GelMA 
hydrogels exhibit αSMA as short cortical stress fibres compared to the 15% GelMA where cells 
expressed long αSMA stress fibres across the whole cytoskeleton. Together these findings suggest that 




Figure 2. Increased substrate stiffness 
promotes αSMA gene and protein 
expression in lung fibroblast. (A) The 
level of αSMA mRNA level was examined 
in lung fibroblasts by the real time RCR 
after culturing on 5%, 10% and 15% of 
GelMA for 24 hours. 18s rRNA was used 
as reference gene for loading control. 
The level on 5% GelMA was set at 1 for 
comparative analysis of RT-PCR. (B) The 
level of αSMA protein from lung 
fibroblasts cultured on 5%, 10% and 15% 
of GelMA for 3 days were determined by 
Western blot. α tubulin was used as 
protein loading control. Representative 
Western blot from 3 independent 
experiments are shown. Relative levels 
of αSMA protein expression were 
determined by densitometry of the blots 
from 3 independent experiments and 
normalised to α tubulin expression. 
(C,D,E) Confocal analysis of αSMA stress 
fibre formation by immunofluorescence 
staining at 4 days after gene silencing. 
Scale bar: 50µm, green= αSMA and 
blue= DAPI nuclei. Results are Mean ± 
SEM, n=3, **p<0.01, ***p<0.001, 
****p<0.0001 
 
Inhibition of ROCK signalling by Y27632 attenuates stiffness induced αSMA expression and fibre 
assembly in myofibroblast  
 
Y27632 is one of the commonly used pharmacological ROCK inhibitors. To investigate the role of  ROCK 
activation in stiffness induced myofibroblast transformation,  lung fibroblasts cultured on 5% and 15% 
GelMA were treated with Y27632 (10uM) for 24 hr. On the stiff matrix (15% GelMA), Y27632 treatment 
caused a significant reduction in αSMA protein level and a complete loss of αSMA fibre assembly 
compared to untreated controls (Figure 3 C and D). In addition, Y27632 treatment decreased the 
Filamentous (F actin) assembly induced by stiff matrix. However on the soft matrix (5% GelMA), we 
did not observe any significance changes in αSMA fibre assembly and αSMA protein level and F actin 






Figure 3.  Y27632 inhibits stiffness induced myofibroblast differentiation.  Lung fibroblasts are cultured on 5% 
(A,B) and 15% GelMA (C,D). The cells were treated with or without Y27632 (10µM) for 24hrs at 2 days after cells 
was cultured on different percentages of GelMA. The cells were stained for αSMA (Alexa Flour 488 - green) and 
F actin (Alexa Flour 647 red and examined by confocal microscopy. Nuclei were stained with DAPI. Scale bar 
=20µm. (E) The level of αSMA protein with or without treatment with Y27632 (10µM) on both 5% and 15% 
GelMA for 24hr were determined by Western blot. α tubulin was used as protein loading control. Relative levels 
of αSMA protein expression were determined by densitometry of the blots from 3 independent experiments 
and normalised to α tubulin protein. Results are Mean ± SEM, n=3, ***p<0.001. 
Differential role of ROCK isoforms in αSMA expression and stress fibre assembly in fibroblasts grown 
on soft and stiff matrix  
To further establish whether ROCK1 and ROCK2 have distinct function in regulation of stiffness 
induced αSMA expression, SiRNA gene silencing was used to knock down ROCK1 and ROCK2 isoforms 
specifically. As shown in Figure 4, ROCK1 and ROCK2 isoforms could be suppressed individually with 
high specificity without affecting the other isoform confirmed by RT-PCR and Western Blotting.  We 
then analysed αSMA expression at gene and protein levels on lung fibroblasts cultured on 5% (soft) 
and 15% (stiff) matrix after ROCK 1 and ROCK2 knockdown (Figure 5). RT-PCR analysis showed that 
silencing of ROCK isoforms individually or both isoforms simultaneously in fibroblasts cultured on soft 
matrix reduced αSMA mRNA expression by approximately 40% and 60% respectively without a 
significant change in αSMA protein level. However, paradoxically silencing individual ROCK isoforms, 
particularly ROCK 2, in fibroblasts cultured on stiff substrate led to a significant increase in αSMA 
mRNA expression whereas silencing both isoforms returned αSMA mRNA expression back to control 
levels. Western blot analysis confirmed a similar pattern for protein expression in lung fibroblasts up 
to 4 days after transfection on stiff matrix. These data were in line with confocal microscopy showing 
the formation of thick αSMA stress fibre assembly in ROCK1 or ROCK2 deficient fibroblasts, on stiff 
matrix compared to ROCK1 or ROCK 2 deficient cells cultured on soft matrix where we did not observe 
the change in the αSMA fibre assembly compared to control ROCK expressed cells. Importantly the 
knockdown of both ROCK isoforms simultaneously was associated with complete inhibition of αSMA 
stress fibre assembly in cells cultured on stiff matrix (Figure 5) indicating the primary function of ROCK 
isoforms in the αSMA fibre assembly rather than synthesis and breakdown of αSMA protein. In order 
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to examine whether these findings are reproducible on another hydrogel system, we also repeated 
same experiment on polyacrylamide hydrogel which is also widely used in stiffness studies (5, 7, 15, 
32, 33). Consistent with data obtained from GelMA hydrogels, increased αSMA level with thick fibre 
assembly was observed on the stiff polyacrylamide hydrogels in the absence of one ROCK isoform 
(Figure S3) proving that our findings are regardless of type of hydrogel system and mainly due to 
substrate stiffness. 
Figure 4. Specificity and 
efficiency of ROCK isoforms 
gene silencing in lung 
fibroblasts on 5% and 15% 
GelMA. ROCK1 and ROCK2 
isoform was knocked down on 
5% GelMA (A,B,C,D) and 15% 
GelMA (E,F,G,H) individually 
and in combination by SiRNA 
gene silencing. (A,C,E,G) The 
level of ROCK1 and ROCK2 
isoform mRNA level were 
examined in lung fibroblasts by 
RT RCR at 2 days after 
transfection to assess 
specificity and efficiency of 
gene knockdown.  18s rRNA 
was used as reference control. 
The level of mRNA in sample 
transfected with non-targeted 
SiRNA was set at 1 for 
comparative analysis of RT-
PCR. (B,D,F,H) The ROCK1 and 
ROCK2 protein level was also 
checked by western blotting at 
4 days after transfection. α 
Tubulin was used as protein 
loading control in WB analysis 
(n=3).  Relative levels of αSMA 
protein expression of 4 days 
after gene silencing were 
determined by densitometry 
(n=3) normalised to α Tubulin. 
****p<0.0001, Results are 






Figure 5. ROCK isoform regulation of αSMA (gene and protein expression) and stress fibre formation in lung 
fibroblasts cultured on 5% and 15% GelMA. Lung fibroblasts are cultured on 5% (A,B,C) and 15% GelMA (D,E,F) 
for 2 Days for gene analysis and 4 days for protein level detection (B,E)  after ROCK isoform gene silencing. The 
level of αSMA mRNA level was examined by the RT- RCR. rRNA 18s was used as reference control. The level of 
αSMA mRNA from Si Control was set at 1 for comparative analysis in RT-PCR. α Tubulin was used as protein 
loading control in WB analysis (n=3).  Relative levels of αSMA protein expression at 4 days after gene silencing 
were determined by densitometry (n=3) normalised to α Tubulin. Results are Mean ± SEM, n=3, *p<0.05, 
*p<0.01, ***p<0.001, ****p<0.0001, ns=not significant. (C, F) Confocal analysis of αSMA stress fibre formation 
by immunofluorescence staining at 4 days after gene silencing. Scale bar: 20µm, green= αSMA and blue= DAPI 
nuclei staining  
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Loss of αSMA fibre assembly in the absence of ROCK isoforms correlates with diminished F actin 
fibre on stiff matrix  
F actin polymerisation from G actin monomer in cytoplasm is known to be upstream to the αSMA 
promoter activation in nucleus after activation by stiff matrix (7). Therefore, in addition to showing 
αSMA fibre assembly in ROCK isoforms depleted fibroblasts on soft and stiff matrix, we also tried to 
investigate any potential association between ROCK activation and F actin fibre formation under these 
conditions. As shown in figure 6A, there was no change in the F actin fibres formation with ROCK 
isoform depletion on soft matrix. However, on stiff matrix, even though F actin staining did not show 
any significant increase in fibroblasts with individual silencing of ROCK isoform, it was significantly 
reduced when both isoforms are absent which also correlates with the loss of αSMA fibre assembly 
after knocking down of both isoforms (Figure 6B). These data clearly suggest a differential role for 
ROCK signalling in the control of F actin polymerisation in association with αSMA fibre assembly on 
soft and stiff matrices.  
 
Figure 6. ROCK isoform regulation of F actin polymerisation in association with αSMA stress fibre formation 
in lung fibroblasts on soft and stiff matrix. Lung fibroblasts are cultured on 5% GelMA (A) 15% GelMA (B) for 
4days after gene silencing of ROCK isoform. αSMA stress fibre (green) and F actin fibre (red) assembly was 
examined by confocal microscopy. Nuclei are stained with DAPI. Representative images from the three 
independent experiments. Scale bar =20µm   
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ROCK isoform imbalance promotes nuclear translocation of MRTF-A in a stiffness dependent 
manner in favour of αSMA stress fibre assembly 
Myocardin related transcription factor A (MRTF-A) has been shown to be involved in stiffness induced 
myofibroblast differentiation (7) by increasing F actin to G actin protein ratio. Generally actin 
monomers are bound to MTRF-A in the cytoplasm. When the ROCK signalling is activated, G actin 
monomers are released from MRTF-A molecules and polymerise to form F actin fibre assembly and 
MRTF-A is translocated into the nucleus where it promotes the fibrotic gene program. To determine 
the role of MRTFA activation in ROCK isoform dependent changes in stiffness induced myofibroblast 
differentiation, we examined the MRTF-A nuclear localisation in ROCK isoform depleted fibroblasts on 
5% and 15% GelMA. Interestingly, immunofluorescent analysis demonstrated increased nuclear 
localisation of MRTF-A (30 to 40%) in lung fibroblasts with single ROCK isoform depletion on 15% 
GelMA compared to control (transfected with scrambled siRNA) and cells where both ROCK isoforms 
were knockdown (Figure 7D). This was opposite to cells cultured on the 5% GelMA where the 
increased nuclear localisation of MRTF-A was not detected in all conditions (Figure 7B).  Taken 
together, these data support the important role of MRTF-A transcriptional factor activation in 
induction of αSMA gene expression and protein synthesis when one ROCK isoform was absent in lung 
fibroblast cultured on a stiff matrix. 
 
Figure 7. ROCK isoform regulation of matrix stiffness induced nuclear localisation of MRTF-A in lung 
fibroblasts. Lung fibroblasts are cultured on the 5% (A, B) and 15% GelMA (C, D). The cells were fixed at 3 Days 
after gene silencing of ROCK isoform and stained for MRTF-A (Alexa Flour 488 – green colour). Nuclear 
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localisation of MRTF-A was examined by confocal imaging and overlaid with DAPI nuclei (blue colour) to confirm 
nuclear localisation of MRTF-A. (B, D) The mean Fluorescence intensity (MFI) of subcellular localisation of MRTFA 
was quantified using ImageJ software.  For each condition, MFI of nuclear and cytoplasmic MRTF-A was 
measured in 60 randomly selected cells from three independent experiments. Scale bar =20µm, n=3.  
Discussion 
 
Experiments using pharmacological inhibitors such as Y27632 and Fasudil have shown ROCK activation 
as a critical step in the stiffness induced myofibroblast transformation (5, 7). In addition to showing 
high efficiency in in vitro experiments these pharmacological inhibitors have also shown good efficacy 
in preventing development of lung fibrosis as well as reversing the established fibrosis in the 
bleomycin induced lung fibrosis mouse models (15). However, given the non-selective nature of the 
ROCK inhibitors used in these studies, the relative contribution of ROCK 1 versus ROCK2 isoforms in 
the development of lung fibrosis is yet to be elucidated. Such information could not only enhance our 
understanding of lung fibrosis at the molecular level but could also pave the way for development of 
more effective intervention strategies for treatment of lung fibrosis.  
The main aim of this study was to evaluate the importance of the balance between ROCK 1 and 2 
isoforms and their relative contribution in stiffness induced myofibroblast transformation in lung 
fibroblasts.   Using SiRNA gene silencing, we achieved highly specific knock down of ROCK1 and ROCK2 
isoforms in spite of the high homology between them.  This enabled us to investigate the effect of 
substrate stiffness on αSMA expression and assembly in ROCK1 low, ROCK2 low and ROCK1+2 low lung 
fibroblasts for the first time.  The main conclusion from these experiments is that either of ROCK 
isoforms are sufficient for αSMA expression on soft matrix but both isoforms are required for αSMA 
stress fibre assembly and maintaining the αSMA protein level on stiff matrix suggesting the differential 
role of ROCK isoforms in myofibroblast differentiation on soft and stiff matrix. More importantly, one 
unexpected finding is that the absence of one ROCK isoform on stiff matrix, as opposed to knocking 
down both isoforms simultaneously, leads to a fibroblast phenotype with increased level of αSMA 
with thick αSMA stress fibre assembly. This is opposite to what was observed on a soft matrix where 
αSMA expression was dramatically reduced after knocking down only one ROCK isoform.  
Additionally, the aggressive myofibroblast features are more prominent in the absence of ROCK 2 
isoform suggesting a more dominant role for ROCK1 isoform in controlling αSMA gene expression and 
fibre assembly. Together these findings highlight the importance of ROCK isoform balance in 
maintaining fibroblasts normal phenotype and the fact that inhibiting individual ROCK isoforms (as 
opposed to simultaneous inhibition of both) could accelerate myofibroblast transformation on an 
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already stiff matrix (e.g. fibrotic lung).   Therefore, since on a stiff matrix, the total loss of αSMA 
assembly could be achieved only in the absence of both isoforms, it is reasonable to suggest that 
targeting both ROCK isoforms would be a safer pharmacological intervention for controlling 
myofibroblast in fibrosis.  
Interestingly our data show that knocking down both ROCK isoforms in cells cultured on stiff matrix 
do not reduce the αSMA protein expression back to the levels observed in cells cultured on soft matrix. 
This finding is inconsistent with our observations when using ROCK inhibitor Y27632 where αSMA 
protein level was reduced significantly within 24hours treatment with Y27632. The possible 
explanation is that Y27632 has additional effect in controlling αSMA synthesis and breakdown through 
other kinases rather than ROCK signalling.  Furthermore we can argue that even though ROCK isoform 
gene silencing achieved high efficiency about 75% in our experiments, the stimulus from the stiff 
matrix was strong enough to activate the low level of ROCK kinase in myofibroblast to maintain the 
αSMA expression at high level. These data highlight the importance of a continuous drive from 
surrounding stiff matrix in influencing myofibroblasts phenotype. Additionally, the loss of αSMA fibre 
assembly correlated with diminished F actin polymerisation not only in the absence of both ROCK 
isoforms but also in Y27632 treated samples highlighting the critical role of ROCK activation in the 
contractile function of myofibroblast by controlling both αSMA fibre assembly and F actin fibre 
polymerisation on a stiff matrix.  
MRTF-A activation has shown to be involved in stiffness induced myofibroblast transformation as actin 
dynamics sensor (14). Our data showing an increase in nuclear translocation of MRTF-A in the absence 
of one ROCK isoform in myofibroblasts on stiff matrix suggest the possible link between increased 
αSMA expression with mature αSMA fibre assembly and changes in actin dynamics in these 
conditions. One explanation is that ROCK isoform imbalance on stiff matrix increased F - G actin ratio 
that favours the MRTF-A nuclear localisation and trans activates the αSMA gene expression. As Rho-
ROCK-MRTF-A signalling pathway has been implicated in controlling myofibroblast differentiation in 
lung fibrosis, our data further highlights the association between MRTF-A and ROCK isoform in 
stiffness induced myofibroblast differentiation.  Further investigations are required to explain how 
MRTFA nuclear translocation affects increase in αSMA profile when one ROCK isoform is depleted in 
myofibroblast on stiff matrix.   
In summary, our study provides a detailed understanding of the role of ROCK isoforms in the 
regulation of stiffness induced myofibroblast transformation and highlight the importance of ROCK 
isoform balance in lung fibrosis. This new insight could inform future attempts for developing 
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